CSCs are identified by their surface markers as CD34+/CD38- in leukemia, CD44+/CD24- in breast cancer, etc. John Dick (1997) was the first to isolate leukemia stem cells in acute myeloid leukemia (AML) patients [89, 90]. This evidence concerns the gene CD38 and acute myeloid leukemia.